Robert Spiera, Md

This study is testing whether adding the medication TAVNEOS to standard treatment helps control ear, nose, and throat symptoms in people with granulomatosis with polyangiitis (GPA), a rare autoimmune disease. About 30 participants with active GPA affecting these areas will receiv…